Learn More About the PROSERA Study
Now enrolling: The PROSERA phase 3 study of seralutinib in adults with pulmonary arterial hypertension.
Real-world referral patterns of PAH patients to pha-accredited comprehensive care centers in the state of Texas 2019-2020